Werewolf Therapeutics Inc

NASDAQ:HOWL   3:59:57 PM EDT
14.52
-0.45 (-3.01%)
Earnings Announcements

Werewolf Therapeutics Says Net Loss Was $7.4 Million For Q1 2021, Compared To $3.8 Million For Same Period In 2020

Published: 06/10/2021 11:33 GMT
Werewolf Therapeutics Inc (HOWL) - Werewolf Therapeutics Reports First Quarter 2021 Financial Results.
Werewolf Therapeutics Inc - As of March 31, 2021, Cash and Cash Equivalents Decreased to $84.6 Million, Compared to $92.6 Million As of December 31, 2020.
Werewolf Therapeutics Inc - Net Loss Was $7.4 Million for Q1 of 2021, Compared to $3.8 Million for Same Period in 2020.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.